Potential For Personalising Treatment Of Infant Osteosarcoma

A team of specialists at the University Hospital of Navarra have revealed the existence of genetic variants that have greater resistance to a specific treatment and a greater toxicity of the pharmaceutical drug in some child patients affected by osteosarcoma. The team investigated the mechanisms of the illness in order to obtain a personalised therapeutic treatment in the future.

source : www.medicalnewstoday.com

Related News:

• European Medicines Agency Makes Recommendations To Minimise Risk Of…
• Breast Enhancement Surgeon on Long Island Nominated a "Best Of"
• $16 Million Grant From State Stem Cell Agency To Speed Research Of…
• Book and Media Reviews: American Psychiatric Publishing Textbook of…
• After Mastectomy: Making a Decision About Breast Reconstruction
• Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of…
• UM Doctor To Lead Clinical Trial For ALS
• Migraine as inspiration
• Impax Pharmaceuticals Reports Positive Results of Phase II Trial of…
• Analysis of TB treatment studies identifies gaps in guidelines

Details :
Submited at Friday, February 20th, 2009 at 9:01 am on Orthopaedic by madison
Comment RSS 2.0 - leave a comment - trackback